Found 10 matching trials
DIABGAD - Trial to Preserve Insulin Secretion in Type 1 Diabetes Using GAD-Alum (Diamyd) in Combination With Vitamin D and Ibuprofen PHASE2 The objectives of this study is to
* evaluate the safety and influence of ...
Show More Location
Halmstad Hospital
Learn More & Join Trial
Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes PHASE2 This is a randomized, placebo-controlled phase II study to investigate if a...
Show More Learn More & Join Trial
A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes PHASE3 The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three...
Show More Location
Mary and Dick Allen Diabetes Center at Hoag Hospital
Learn More & Join Trial
Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes PHASE1 The objective of the study is to evaluate the feasibility and safety of adm...
Show More Location
Kliniska Forskningsenheten (Hudmottagningen), Universitetssjukhuset Linköping
Learn More & Join Trial
Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes PHASE2 A 2-arm randomized Phase II Open Label Study to evaluate the safety and fea...
Show More Status
Active Not Recruiting
Location
Lund University/CRC, Skåne University Hospital,
Learn More & Join Trial
EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes PHASE2 The objectives of this study is to:
* Evaluate the tolerability of a combi...
Show More Location
Helsingborg Hospital
Learn More & Join Trial
Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes PHASE2 The objective of DIAGNODE-2 is to evaluate the efficacy of Diamyd compared ...
Show More Location
Diabetes Centre, Institute of Clinical and Experimental Medicine
Learn More & Join Trial
A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU) PHASE3 The purpose of this study is to determine whether Diamyd (rhGAD65 formulate...
Show More Location
Helsingin yliopistollinen keskussairaala, Lasten ja nuorten sairaala
Learn More & Join Trial
GAD-Alum (Diamyd) Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes (DIAGNODE-1) PHASE1 The objectives of the main study is to:
* Evaluate the safety of giving GA...
Show More Location
Linköping University
Learn More & Join Trial
Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 Diabetes PHASE2 Background:
* Type 1 diabetes (T1D) occurs when the immune system attacks ...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial